BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 10462068)

  • 1. Cannabinoids as potential new analgesics.
    Fuentes JA; Ruiz-Gayo M; Manzanares J; Vela G; Reche I; Corchero J
    Life Sci; 1999; 65(6-7):675-85. PubMed ID: 10462068
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction of the cannabinoid and opioid systems in the modulation of nociception.
    Welch SP
    Int Rev Psychiatry; 2009 Apr; 21(2):143-51. PubMed ID: 19367508
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Opioids and cannabinoids interactions: involvement in pain management.
    Desroches J; Beaulieu P
    Curr Drug Targets; 2010 Apr; 11(4):462-73. PubMed ID: 20017728
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of cannabinoid receptor in the brain as it relates to drug reward.
    Yamamoto T; Takada K
    Jpn J Pharmacol; 2000 Nov; 84(3):229-36. PubMed ID: 11138722
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current evidence of cannabinoid-based analgesia obtained in preclinical and human experimental settings.
    Lötsch J; Weyer-Menkhoff I; Tegeder I
    Eur J Pain; 2018 Mar; 22(3):471-484. PubMed ID: 29160600
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endocannabinoids and pain: spinal and peripheral analgesia in inflammation and neuropathy.
    Rice AS; Farquhar-Smith WP; Nagy I
    Prostaglandins Leukot Essent Fatty Acids; 2002; 66(2-3):243-56. PubMed ID: 12052040
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Participation of the opioid system in cannabinoid-induced antinociception and emotional-like responses.
    Maldonado R; Valverde O
    Eur Neuropsychopharmacol; 2003 Dec; 13(6):401-10. PubMed ID: 14636956
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Interactions between the opioid and cannabinoid systems].
    Beaulieu P
    Ann Fr Anesth Reanim; 2000 Mar; 19(3):217-8. PubMed ID: 10782249
    [No Abstract]   [Full Text] [Related]  

  • 9. Cannabinoid analgesia.
    Walker JM; Huang SM
    Pharmacol Ther; 2002 Aug; 95(2):127-35. PubMed ID: 12182960
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antinociception mechanisms of action of cannabinoid-based medicine: an overview for anesthesiologists and pain physicians.
    Narouze S
    Reg Anesth Pain Med; 2021 Mar; 46(3):240-250. PubMed ID: 33239391
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cannabinoid-opioid interactions during neuropathic pain and analgesia.
    Bushlin I; Rozenfeld R; Devi LA
    Curr Opin Pharmacol; 2010 Feb; 10(1):80-6. PubMed ID: 19857996
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular and cellular basis of cannabinoid and opioid interactions.
    Viganò D; Rubino T; Parolaro D
    Pharmacol Biochem Behav; 2005 Jun; 81(2):360-8. PubMed ID: 15927245
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Role of the Cannabinoid System in Opioid Analgesia and Tolerance.
    Ozdemir E
    Mini Rev Med Chem; 2020; 20(10):875-885. PubMed ID: 32167427
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of improgan antinociception by the cannabinoid (CB)(1) antagonist N-(piperidin-1-yl)-5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-1H-pyrazole-3-carboxamide (SR141716A): lack of obligatory role for endocannabinoids acting at CB(1) receptors.
    Hough LB; Nalwalk JW; Stadel R; Timmerman H; Leurs R; Paria BC; Wang X; Dey SK
    J Pharmacol Exp Ther; 2002 Oct; 303(1):314-22. PubMed ID: 12235266
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cellular mechanisms underlying the interaction between cannabinoid and opioid system.
    Parolaro D; Rubino T; Viganò D; Massi P; Guidali C; Realini N
    Curr Drug Targets; 2010 Apr; 11(4):393-405. PubMed ID: 20017730
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cannabinoid transmission and pain perception.
    Martin BR; Lichtman AH
    Neurobiol Dis; 1998 Dec; 5(6 Pt B):447-61. PubMed ID: 9974177
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synergistic interactions between cannabinoid and opioid analgesics.
    Cichewicz DL
    Life Sci; 2004 Jan; 74(11):1317-24. PubMed ID: 14706563
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Motivational effects of cannabinoids and opioids on food reinforcement depend on simultaneous activation of cannabinoid and opioid systems.
    Solinas M; Goldberg SR
    Neuropsychopharmacology; 2005 Nov; 30(11):2035-45. PubMed ID: 15812567
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The neurobiology of cannabinoid analgesia.
    Walker JM; Hohmann AG; Martin WJ; Strangman NM; Huang SM; Tsou K
    Life Sci; 1999; 65(6-7):665-73. PubMed ID: 10462067
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Spinal and peripheral mechanisms of cannabinoid antinociception: behavioral, neurophysiological and neuroanatomical perspectives.
    Hohmann AG
    Chem Phys Lipids; 2002 Dec; 121(1-2):173-90. PubMed ID: 12505699
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.